Blog

»  Posts By   August 2019 

Frier Levitt Helps Pharmacy Reverse PBM Termination

Frier Levitt recently reversed a PBM's decision to terminate a pharmacy due to alleged drug invoice shortage discrepancies. The pharmacy was terminated due to the results of a PBM's pre-credentialing audit that failed to take into account a variety of purchases made during and prior to the audit period. The PBM also failed to take into account an inventory that was purchased from the previous owner of the pharmacy. Using...

Frier Levitt Negotiates Access to PBM Network for Previously Denied Pharmacy

Frier Levitt recently negotiated a contract with a PBM network for a pharmacy that had been denied entry on several previous occasions. The pharmacy had applied for a contract numerous times and was denied for various reasons for more than a year, eventually seeking legal assistance from Frier Levitt. Frier Levitt intervened and through application of in-depth knowledge of legal requirements and the PBM application process, assisted the pharmacy to...

NJ Client ALERT: Gabapentin Prescribing Receiving Higher Scrutiny Under New Evidence of Abuse

On May 7, 2018, the New Jersey Division of Consumer Affairs began requiring pharmacies begin reporting prescriptions for the unscheduled drug gabapentin to the New Jersey Prescription Monitoring Program (PMP). The drug, known under brand names Neurontin and Gralise, is currently unscheduled. However Michigan, Ohio, Kentucky, and West Virginia have all reclassified gabapentin as Schedule V, while other states are currently debating whether to schedule gabapentin as well. It has...